Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
51.62
Dollar change
-0.26
Percentage change
-0.50
%
Index- P/E- EPS (ttm)-2.82 Insider Own4.35% Shs Outstand85.17M Perf Week1.69%
Market Cap4.38B Forward P/E- EPS next Y-5.04 Insider Trans-0.24% Shs Float81.47M Perf Month13.73%
Income-239.59M PEG- EPS next Q-1.26 Inst Own65.63% Short Float21.59% Perf Quarter10.04%
Sales202.83M P/S21.61 EPS this Y-170.07% Inst Trans0.94% Short Ratio15.75 Perf Half Y0.88%
Book/sh22.73 P/B2.27 EPS next Y3.90% ROA-11.03% Short Interest17.59M Perf Year-5.67%
Cash/sh22.79 P/C2.26 EPS next 5Y-3.70% ROE-13.07% 52W Range43.42 - 91.10 Perf YTD-17.54%
Dividend Est.- P/FCF- EPS past 5Y10.83% ROI-11.14% 52W High-43.34% Beta1.62
Dividend TTM- Quick Ratio21.64 Sales past 5Y33402.13% Gross Margin26.23% 52W Low18.89% ATR (14)2.10
Dividend Ex-Date- Current Ratio21.64 EPS Y/Y TTM37.49% Oper. Margin-163.88% RSI (14)61.02 Volatility5.12% 4.10%
Employees407 Debt/Eq0.12 Sales Y/Y TTM19.31% Profit Margin-118.13% Recom2.16 Target Price80.24
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q28.60% Payout- Rel Volume1.17 Prev Close51.88
Sales Surprise-90.83% EPS Surprise27.06% Sales Q/Q- EarningsNov 05 BMO Avg Volume1.12M Price51.62
SMA205.47% SMA508.78% SMA200-10.80% Trades Volume1,303,683 Change-0.50%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Reiterated Needham Buy $88 → $84
Aug-02-24Initiated Rodman & Renshaw Buy $90
Jun-28-24Resumed Guggenheim Neutral
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-11-23Downgrade TD Cowen Market Perform → Underperform $30
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-27-23Initiated Mizuho Buy $82
Aug-17-23Upgrade Citigroup Neutral → Buy
May-30-23Initiated William Blair Outperform $75
Apr-13-23Initiated Cantor Fitzgerald Overweight $72
Nov-08-24 05:20PM
01:22PM
Nov-07-24 08:00AM
Nov-06-24 12:42PM
09:55AM
10:10AM Loading…
Nov-05-24 10:10AM
09:01AM
05:00AM
Nov-04-24 09:35AM
09:30AM
Nov-02-24 10:00AM
Oct-31-24 04:02AM
Oct-26-24 06:32AM
Oct-25-24 05:50PM
Oct-22-24 11:50AM
06:00PM Loading…
Oct-21-24 06:00PM
09:55AM
Oct-19-24 07:30AM
Oct-16-24 03:47PM
09:45AM
Oct-15-24 06:00PM
Oct-13-24 06:30AM
Oct-12-24 08:30AM
Oct-08-24 06:00PM
Oct-05-24 04:25AM
Oct-04-24 07:13PM
Oct-02-24 06:00PM
05:00AM
04:55AM
Sep-25-24 06:00PM
07:36AM Loading…
Sep-21-24 07:36AM
Sep-19-24 05:50PM
04:33AM
Sep-18-24 06:00PM
Sep-12-24 08:45AM
04:15AM
Sep-10-24 05:50PM
Sep-08-24 04:51PM
11:49AM
Sep-05-24 08:45AM
Sep-04-24 11:30AM
Sep-02-24 06:15PM
Aug-30-24 08:19PM
Aug-26-24 07:30AM
Aug-19-24 11:43AM
Aug-11-24 07:28AM
Aug-09-24 10:19AM
Aug-08-24 04:56PM
06:00AM
Aug-07-24 09:00AM
Aug-06-24 10:37AM
Aug-05-24 05:25PM
04:01PM
Aug-04-24 06:22AM
Aug-01-24 12:21PM
Jul-31-24 09:45AM
Jul-30-24 09:00AM
Jul-29-24 04:00PM
10:00AM
Jul-26-24 05:50PM
Jul-24-24 08:53AM
Jul-23-24 06:00PM
09:48AM
Jul-22-24 04:45PM
Jul-20-24 06:00AM
Jul-17-24 01:30PM
11:30AM
06:08AM
Jul-16-24 01:37PM
04:15AM
Jul-11-24 08:45AM
Jul-10-24 06:00PM
Jul-09-24 07:59AM
07:30AM
07:00AM
Jul-08-24 09:00AM
06:00AM
Jul-03-24 03:11PM
Jul-01-24 08:40PM
02:31PM
Jun-27-24 10:02PM
06:39PM
03:38PM
02:21PM
08:00AM
06:40AM
Jun-26-24 09:33PM
06:00PM
Jun-25-24 08:00AM
Jun-24-24 10:54AM
09:00AM
Jun-20-24 06:00PM
Jun-19-24 02:46PM
Jun-13-24 05:50PM
Jun-12-24 06:30PM
01:44PM
Jun-11-24 09:00AM
Jun-09-24 06:20AM
Jun-07-24 11:30AM
11:25AM
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KASINGER JAMES R.General Counsel and SecretaryOct 14 '24Sale46.281,08950,39962,597Oct 15 06:00 PM
Kulkarni SamarthChief Executive OfficerOct 14 '24Sale46.284,293198,680226,540Oct 15 06:00 PM
Bruno JulianneChief Operating OfficerJun 21 '24Sale56.093,366188,7996,745Jun 24 05:35 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Option Exercise19.1219,582374,408227,704Apr 17 05:45 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Sale59.9119,5821,173,232208,122Apr 17 05:45 PM
Prasad RajuChief Financial OfficerMar 15 '24Sale72.693,524256,1606,476Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Option Exercise19.1220,000382,400228,122Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Sale72.4820,0001,449,628208,122Mar 18 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 11 '24Sale78.262,801219,20660,070Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 12 '24Sale74.441,14685,30861,174Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 11 '24Sale78.269,802767,105203,705Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 12 '24Sale74.444,583341,159208,122Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryFeb 20 '24Sale79.671,913152,40957,371Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 20 '24Sale79.676,370507,498194,257Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15 '24Option Exercise19.1220,000382,400207,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15 '24Sale80.3620,0001,607,177187,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29 '24Option Exercise19.1250,000956,000237,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29 '24Sale60.5150,0003,025,573187,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16 '24Option Exercise19.1220,000382,400207,377Jan 18 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16 '24Sale62.5020,0001,250,058187,377Jan 18 05:45 PM